☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
Ascentage Pharma's Alrizomadlin (APG-115) Receives the US FDA’s Rare Pediatric Disease Designation for the Treatment of Neuroblast...
March 22, 2022
uniQure Reports Completion of Patient Enrollment in the First Two Cohorts of P-I/II Trial for AMT-130 to Treat Huntington’s Diseas...
March 22, 2022
Tonix Reports Results of TNX-102 SL in P-III (RALLY) Study for the Treatment of Fibromyalgia
March 22, 2022
Merck’s Keytruda (pembrolizumab) Receives the US FDA’s Approval for the Treatment of MSI‑H/dMMR Advanced Endometrial Carcinoma
March 22, 2022
PharmaShots Interview: Astellas’ John C. Hairston & Gabriel P. Haas Share Insights on Xtandi (enzalutamide) for the Treatment of P...
March 22, 2022
Plus Therapeutics Reports First Patient Dosing in P-I/IIa (ReSPECT-LM) Dose Escalation Trial of 186RNL for Leptomeningeal Metastas...
March 22, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions